Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

(2013) T Schroeder et al.   LEUKEMIA

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

(2012) G W Basak et al.   BONE MARROW TRANSPLANTATION

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant

(2011) K. K. Ballen et al.   BLOOD

Acceptable HLA-mismatching in unrelated donor bone marrow transplantation for patients with acquired severe aplastic anemia

(2011) H. Yagasaki et al.   BLOOD

The EBMT activity survey 2009: trends over the past 5 years

(2011) H Baldomero et al.   BONE MARROW TRANSPLANTATION

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Molecular methods in diagnosis and monitoring of haematological malignancies

(2011) David T. Yeung et al.   PATHOLOGY

Three decades of transplantation for chronic myeloid leukemia: what have we learned?

(2010) J. Pavlu et al.   BLOOD

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

(2010) A. J. Mead et al.   BLOOD

Therapy-related myelodysplastic syndrome after allogeneic BMT: successful treatment by donor lymphocyte infusions

(2010) D Roos-Weil et al.   BONE MARROW TRANSPLANTATION

Successful Prevention of Acute Graft-versus-Host Disease Using Low-Dose Antithymocyte Globulin after Mismatched, Unrelated, Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia

(2009) Hee-Je Kim et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet

(2009) M. C. Bene et al.   HAEMATOLOGICA

HLA-Identical Sibling Compared With 8/8 Matched and Mismatched Unrelated Donor Bone Marrow Transplant for Chronic Phase Chronic Myeloid Leukemia

(2009) Mukta Arora et al.   JOURNAL OF CLINICAL ONCOLOGY

Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3–6/6 HLA matched donors

(2008) D A Rizzieri et al.   BONE MARROW TRANSPLANTATION

Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML

(2008) C F Craddock   BONE MARROW TRANSPLANTATION

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCT

(2008) A Toor et al.   BONE MARROW TRANSPLANTATION

Modified Donor Lymphocyte Infusion after HLA-Mismatched/Haploidentical T Cell-replete Hematopoietic Stem Cell Transplantation for Prophylaxis of Relapse of Leukemia in Patients with Advanced Leukemia

(2008) Xiao-Jun Huang et al.   JOURNAL OF CLINICAL IMMUNOLOGY